SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-047371
Filing Date
2017-08-03
Accepted
2017-08-03 16:39:28
Documents
1
Period of Report
2017-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4437
  Complete submission text file 0001209191-17-047371.txt   5859
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Issuer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address
Boudreau Helen M (Reporting) CIK: 0001661481 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37695 | Film No.: 171005623